Comparison between the combined analysis and the DeMeester score to predict response to PPI therapy

Journal of Clinical Gastroenterology

Volumn 40, Issue 7, 2006, Pages 602-605

  Mainie, Inder ^a   Tutuian, Radu ^a   Castell, Donald O ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

pH monitoring; Sensitive esophagus; Symptom index

Indexed keywords

PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DEMEESTER SCORE; ESOPHAGUS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MAJOR CLINICAL STUDY; MALE; PH MEASUREMENT; PRIORITY JOURNAL; SCORING SYSTEM; STOMACH ACID;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; MONITORING, AMBULATORY; PROTON PUMPS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33747471096     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200608000-00008     Document Type: Article

References (18)

1. Sonnenberg A, El-Serag HB. Clinical epidemiology and natural history of gastroesophageal reflux disease. Yale J Biol Med. 1999;72:81-92.
2. Howard PJ, Heading RC. Epidemiology of gastro-esophageal reflux disease. World J Surg. 1992;16:288-293.
3. Srinivasan R, Tutuian R, Schoenfeld P, et al. Profile of GERD in the adult population of a northeast urban community. J Clin Gastroenterol. 2004;38:651-657.
4. NIH. Digestive Disease Statistics. NIH Publication no. 99-3873. Bethesda, MD: NIH; 1999.
5. Delaney BC. Review article: prevalence and epidemiology of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2004;20:2-4.
6. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2005;100:190-200.
7. Eriksen CA, Cullen PT, Sutton D, et al. Abnormal esophageal transit in patients with typical reflux symptoms but normal endoscopic and pH profiles. Am J Surg. 1991;161:657-661.
8. Wiener GJ, Richter JE, Copper JB, et al. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol. 1988;83:358-361.
9. Shi G, Tatum RP, Joehl RJ, et al. Esophageal sensitivity and symptom perception in gastroesophageal reflux disease. Curr Gastroenterol Rep. 1999;1:214-219.
10. Shi G, Bruley des Varannes S, Scarpignato C, et al. Reflux related symptoms in patients with normal oesophageal exposure to acid. Gut. 1995;37:457-464.
11. Johnson LF, Demeester TR. Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol. 1974;62:325-332.
12. Van Pinxteren B, Numans ME, Lau J, et al. Short-term treatment of gastroesophageal reflux disease. J Gen Intern Med. 2003;18:755-763.
13. Trimble KC, Douglas S, Pryde A, et al. Clinical characteristics and natural history of symptomatic but not excess gastroesophageal reflux. Dig Dis Sci. 1995;40:1098-1104.
14. Wiener GJ, Morgan TM, Copper JB, et al. Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci. 1988;33:1127-1133.
15. Mayer EA, Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology. 1994;107:271-293.
16. Bernstein LM, Baker LA. A clinical test for esophagitis. Gastroenterology. 1958;34:760-781.
17. Watson RG, Tham TC, Johnston BT, et al. Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux - the "sensitive oesophagus." Gut. 1997;40:587-590.
18. Bell RC, Hanna P, Brubaker S. Laparoscopic fundoplication for symptomatic but physiologic gastroesophageal reflux. J Gastrointest Surg. 2001;5:462-467.